Vaccine Packaging Market Size, Share, Growth, Analysis, 2034

(MENAFN- Straits Research) Vaccine Packaging Market Size & Growth Analysis

The global vaccine packaging market size was valued at USD 2.31 billion in 2025 and is estimated to grow from USD 2.47 billion in 2026 to USD 4.16 billion by 2034, registering a CAGR of 6.79% during the forecast period (2026–2034). North America dominated the vaccine packaging market with a market share of 36.24% in 2025.

Vaccine packaging solutions include vials, prefilled syringes, ampoules, cartridges, labels, and temperature-controlled secondary packaging that ensure compliance with stringent regulatory and cold chain requirements. They are widely used for routine immunization programs, pandemic preparedness, travel vaccines, pediatric vaccines, and adult vaccination campaigns across hospitals, clinics, pharmacies, and public health organizations.

The vaccine packaging market demand is driven by expanding global immunization programs, growing production of vaccines, and stringent cold chain requirements. The adoption of prefilled syringes and sustainable packaging materials and expanding healthcare infrastructure also contributes to the vaccine packaging market growth.

Vaccine Packaging Market Key Takeaways

The North America vaccine packaging market accounted for a dominant share of 36.24% in 2025. The Asia Pacific vaccine packaging market is expected to grow at a CAGR of 7.54% during the forecast period. By product type, the prefilled syringes segment is expected to grow at a CAGR of 7.58% during the forecast period. By material, the glass segment accounted for a share of 67.84% in 2025. By packaging type, the primary packaging segment accounted for a share of 72.36% in 2025. By end use, the contract manufacturing organizations (CMOs) segment is expected to grow at a CAGR of 7.81% during the forecast period. The US vaccine packaging market size was valued at USD 0.74 billion in 2025 and is projected to reach USD 0.79 billion in 2026. The Japan vaccine packaging market size was valued at USD 0.18 billion in 2025 and is projected to reach USD 0.19 billion in 2026.

Download a Free Sample To learn more about this report,

Impact of Supply Chain Disruption on Vaccine Packaging Market

The vaccine packaging market is highly exposed to supply chain disruptions due to its reliance on pharmaceutical grade glass, medical polymers, elastomer components, and cold chain logistics. Disruptions in raw material availability, transportation networks, and manufacturing capacity can delay the production and distribution of vaccine packaging, affecting global immunization programs and pharmaceutical supply chains. These challenges have accelerated investments in regional manufacturing, supplier diversification, and cold chain infrastructure to improve supply security and regulatory compliance across global markets. The market is experiencing a capacity-constrained recovery, where demand for vaccine packaging remains strong, but the availability of specialized packaging materials and production capacity continues to limit the pace of market expansion.

Vaccine Packaging Market Trends

Preference for Digital Vaccine Authentication

The need to prevent counterfeit vaccines is driving the transition toward digital vaccine authentication through QR codes, serialization, and unique identification labels. These technologies help verify product authenticity, improve supply chain transparency, and support regulatory compliance. As a result, manufacturers and healthcare providers are strengthening the security of vaccine distribution. For example, Systech provides pharmaceutical serialization and traceability solutions that support vaccine authentication.

Shift toward Blow Fill Seal (BFS) Packaging

Greater focus on aseptic manufacturing and production efficiency is driving the transition toward blow fill seal (BFS) packaging. This technology forms, fills, and seals containers in a single automated process, reducing contamination risks and improving manufacturing consistency. As a result, pharmaceutical companies are using BFS systems for selected sterile injectable products.

Vaccine Packaging Market Investment and Funding Analysis

The vaccine packaging market forecasts continued investment activity driven by the growing production of vaccines, stringent cold chain requirements, and rising demand for advanced sterile packaging solutions.

Key Investment and Funding Activities in Vaccine Packaging Market, 2025-2026

Company	Value (USD)	Details
SCHOTT Pharma	USD 60 Million	In June 2026, SCHOTT Pharma inaugurated expanded core and specialty vial production capacity at its Lebanon, Pennsylvania site, backed by an investment largely funded by the Biomedical Advanced Research and Development Authority (BARDA) to reinforce the US domestic medical and vaccine supply chain.
BD (Becton, Dickinson and Company)	USD 35 Million	In August 2025, BD announced an investment to expand its Nebraska facility's prefilled flush syringe production capacity, strengthening domestic healthcare containment and delivery infrastructure.

Vaccine Packaging Market Dynamics Market Drivers

National Immunization Programs and Vaccine Manufacturing Capacity Drives Market

National immunization programs are driving demand for vaccine packaging across public healthcare systems. According to the World Health Organization (WHO) and UNICEF, 116 million infants (90%) received at least one dose of the diphtheria, tetanus, and pertussis (DTP) vaccine, while 110 million infants (85%) completed the three-dose series under the 2026 WUENIC estimates. The large volume of vaccine doses administered requires substantial supplies of vials, prefilled syringes, labels, cartons, and temperature-controlled packaging.

The establishment of new vaccine manufacturing facilities is driving demand for vaccine packaging solutions. Pharmaceutical companies and contract manufacturers require a continuous supply of sterile vials, closures, prefilled syringes, and secondary packaging to support commercial production and global distribution. The commissioning of new manufacturing lines for routine and specialty vaccines is creating sustained demand for high-quality pharmaceutical packaging across the supply chain.

Market Restraints

Limited Pharmaceutical Glass Supply and Strict Sterility Requirements Restrain Market Expansion

Limited availability of pharmaceutical-grade glass restricts the production of vaccine vials and other primary packaging components. Manufacturers often face procurement delays and longer lead times for high-quality glass containers. This affects packaging availability and slows the timely supply of vaccines to healthcare providers.

Strict sterility requirements make vaccine packaging manufacturing more complex and resource intensive. Packaging components must meet rigorous contamination control and quality assurance standards before commercial use. This raises production costs and limits the entry of new manufacturers into the vaccine packaging market.

Market Opportunities

Regional Vaccine Stockpiles and Needle-Free Vaccine Delivery Offer Growth Opportunities to Market Players

Government efforts to establish regional vaccine stockpiles are creating growth opportunities for vaccine packaging manufacturers and contract packaging companies. Strategic vaccine reserves require durable primary containers and validated secondary packaging with long shelf life. This creates long-term supply opportunities for packaging suppliers supporting public health agencies. Companies such as SCHOTT Pharma and Gerresheimer supply pharmaceutical packaging products used for vaccine storage and distribution.

The development of needle-free vaccine delivery systems is creating growth opportunities for packaging manufacturers and device developers. New delivery formats require customized packaging that ensures sterility, product compatibility, and ease of administration. This creates future demand for application-specific packaging solutions as alternative vaccine delivery technologies enter the market.

Market Challenges

Counterfeit Vaccine Circulation and Frequent Labeling and Artwork Update Challenges Market Growth

The circulation of counterfeit vaccines affects confidence in pharmaceutical supply chains and increases the need for additional verification measures. Manufacturers must invest in enhanced packaging security and compliance processes, adding operational complexity and costs. This delays product launches and affects the overall pace of market growth.

Changes in regulatory guidelines, dosage information, and multilingual labeling requirements require frequent updates to vaccine packaging artwork. Manufacturers must revise packaging materials and manage multiple stock-keeping units, increasing production complexity and lead times.

Vaccine Packaging Market Segmentation Analysis By Product Type

The vials segment accounted for a share of 48.36% in 2025, owing to the widespread use for routine immunization programs, multidose vaccine presentations, and compatibility with a broad range of vaccine formulations. High filling efficiency, ease of storage, and established cold chain infrastructure further support demand across global vaccine manufacturers.

The prefilled syringes segment is expected to grow at a CAGR of around 7.58% during the forecast period, driven by improved dosing accuracy, reduced contamination risk, and greater convenience during vaccine administration. The preference for ready-to-administer vaccines and efforts to minimize vaccine wastage continue to support segment demand.

Request Customization to receive a tailored report.

By Material

The glass segment accounted for a share of 67.84% in 2025 due to its excellent chemical resistance, high barrier properties, and compatibility with temperature-sensitive biologics. Glass packaging maintains vaccine stability and remains the preferred material for injectable vaccines requiring long-term storage.

The polymer segment is expected to grow at a CAGR of 7.34% during the forecast period, fueled by the demand for lightweight, break-resistant packaging and improved transportation efficiency. Advancements in pharmaceutical-grade polymers and compatibility with selected vaccine formulations continue to support adoption.

By Packaging Type

The primary packaging segment accounted for a share of 72.36% in 2025, supported by its direct contact with vaccine formulations, ensuring sterility, product stability, and protection during storage, transportation, and administration. Vials, prefilled syringes, ampoules, and closures remain the most widely used primary packaging formats.

The secondary packaging segment is expected to grow at a CAGR of 7.18% during the forecast period, propelled by the need for product protection, cold chain compatibility, regulatory labeling, and efficient transportation. A strong focus on global vaccine distribution and traceability continues to support demand for cartons and insulated packaging.

By End Use

The pharmaceutical & biotechnology companies segment accounted for a share of 61.42% in 2025 due to high vaccine manufacturing volumes, extensive filling and packaging operations, and investment in sterile packaging infrastructure. These companies require reliable packaging solutions for commercial vaccine production and global distribution.

The contract manufacturing organizations (CMOs) segment is expected to grow at a CAGR of 7.81% during the forecast period, driven by outsourcing of vaccine production, fill finish operations, and packaging services.

Speak to an Analyst to discuss market opportunities.

Vaccine Packaging Market Regional Outlook North America Vaccine Packaging Market Analysis

North America: Market Dominance Led by Strong Vaccine Manufacturing Base and Advanced Cold Chain Infrastructure

The North America vaccine packaging market accounted for the largest regional share of 37.18% in 2025, driven by the presence of leading vaccine manufacturers, advanced pharmaceutical packaging capabilities, and well-established cold chain infrastructure. The region also benefits from stringent regulatory standards, widespread use of sterile packaging technologies, and high demand for routine and specialty vaccines.

US Vaccine Packaging Market Analysis

The US vaccine packaging market was valued at USD 0.74 billion in 2025, driven by high vaccine production capacity, extensive pharmaceutical manufacturing infrastructure, and continued investment in sterile fill finish operations. Manufacturers are adopting advanced primary and secondary packaging solutions to maintain product stability, regulatory compliance, and cold chain integrity. According to the U.S. Centers for Disease Control and Prevention (CDC), the 2026 Adult Immunization Schedule recommends routine vaccination against multiple infectious diseases, supporting sustained demand for vaccine packaging solutions.

Canada Vaccine Packaging Market Analysis

The Canada vaccine packaging market was valued at USD 0.13 billion in 2025, supported by national immunization programs, domestic biomanufacturing initiatives, and investments in pharmaceutical supply chain resilience. The country continues to strengthen vaccine production and distribution capabilities through public health investments and strategic partnerships. A strong focus on cold chain logistics and pharmaceutical packaging quality supports market demand.

Unlock Regional Insights to access country-level data, & regional trends.

Asia Pacific Vaccine Packaging Market Analysis

Asia Pacific: Fastest Growth Driven by Vaccine Manufacturing Capacity and Pharmaceutical Production

The Asia Pacific vaccine packaging market is expected to grow at a CAGR of 7.54% during the forecast period, representing the fastest regional growth. Growth is supported by expanding vaccine manufacturing capacity, strengthening pharmaceutical production infrastructure, and government initiatives to improve vaccine access across developing economies. The region is also witnessing greater investment in sterile packaging technologies and cold chain logistics.

China Vaccine Packaging Market Analysis

The China vaccine packaging market was valued at USD 0.29 billion in 2025, driven by large-scale vaccine manufacturing, expanding biologics production, and investment in pharmaceutical packaging technologies. Government support for domestic vaccine production and export activities continues to strengthen demand for high-quality primary and secondary packaging solutions. The country's integrated pharmaceutical supply chain further supports market development.

India Vaccine Packaging Market Analysis

The India vaccine packaging market was valued at USD 0.16 billion in 2025, driven by strong vaccine manufacturing capabilities, expanding contract manufacturing activities, and national immunization initiatives. According to India's Ministry of Health and Family Welfare, the Universal Immunization Programme (UIP) provides vaccines against 12 vaccine-preventable diseases, supporting sustained demand for vaccine packaging. Ongoing investments in biopharmaceutical manufacturing further support market development.

Japan Vaccine Packaging Market Analysis

The Japan vaccine packaging market was valued at USD 0.18 billion in 2025, supported by advanced pharmaceutical manufacturing, stringent quality standards, and continuous demand for routine and adult immunization vaccines. Japan recorded approximately 48.6 million doses of routine vaccinations as the average annual use over the previous three years (Source: Ministry of Health, Labour and Welfare, Japan). This sustained vaccine volume supports continued demand for vials, cartons, labels, and temperature-controlled packaging across the vaccine supply chain. The country's mature pharmaceutical industry and advanced cold chain infrastructure continue to support demand for premium vaccine packaging.

Competitive Landscape

The vaccine packaging market competitive landscape is moderately consolidated, with competition concentrated among established pharmaceutical packaging companies specializing in primary packaging, sterile packaging, and cold chain solutions. Leading players compete through advancements in packaging materials, container integrity, temperature protection, regulatory compliance, and long-standing partnerships with vaccine manufacturers. Emerging companies focus on developing sustainable packaging solutions, improving production efficiency, and strengthening global supply capabilities.

List of Key and Emerging Players in Vaccine Packaging Market

SCHOTT Pharma (Germany) Gerresheimer AG (Germany) West Pharmaceutical Services, Inc. (US) Stevanato Group S.p.A. (Italy) SGD Pharma (France) Nipro Corporation (Japan) Becton, Dickinson and Company (US) AptarGroup, Inc. (US) Corning Incorporated (US) DWK Life Sciences GmbH (Germany) Ompi (Italy) Piramal Pharma Limited (India) Datwyler Holding Inc. (Switzerland) Berry Global Group, Inc. (US) Amcor plc (Switzerland)

Recent Industry Developments

July 2026: Gerresheimer AG announced the opening of a new pharmaceutical primary glass packaging manufacturing plant in Zhenjiang, China.

June 2026: SCHOTT Pharma completed the expansion of its vial production facility in Lebanon, Pennsylvania (US), adding new production lines for standard and ready-to-use (RTU) glass vials used for vaccines and biologics.

April 2026: SCHOTT Pharma announced the development of cartriQ BioPure, a new sterile glass cartridge designed for sensitive biologics.

Report Scope

Market Metric	Details & Data (2025-2034)
Market Size in 2025	USD 2.31 Billion
Market Size in 2026	USD 2.47 Billion
Market Size in 2034	USD 4.16 Billion
CAGR	6.76% (2026-2034)
Base Year for Estimation	2025
Historical Data	2022-2024
Forecast Period	2026-2034
Study Period	2022-2034
Dominant Region	North America
Fastest Growing Region	Asia Pacific
Key Market Players	SCHOTT Pharma (Germany), Gerresheimer AG (Germany), West Pharmaceutical Services, Inc. (US), Stevanato Group S.p.A. (Italy), SGD Pharma (France)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
Segments Covered	By Product Type, By Material, By Packaging Type, By End Use
Geographies Covered	North America, Europe, APAC, Middle East and Africa, LATAM
Countries Covered	US, Canada, UK, Germany, France, Spain, Italy, Russia, Nordic, Benelux, China, Korea, Japan, India, Australia, Taiwan, South East Asia, UAE, Turkey, Saudi Arabia, South Africa, Egypt, Nigeria, Brazil, Mexico, Argentina, Chile, Colombia

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

MENAFN07092026004597010906ID1111631078